Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes

Y. H. Chen, S. N. Chen, R. I. Lien, C. P. Shih, A. N. Chao, K. J. Chen, Y. S. Hwang, N. K. Wang, Y. P. Chen, K. H. Lee, C. C. Chuang, T. L. Chen, C. C. Lai, W. C. Wu*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

53 Scopus citations

Abstract

Purpose To evaluate the refractive outcomes in children treated after intravitreal injection of bevacizumab (IVB) for retinopathy of prematurity (ROP).Methods A retrospective, bi-centre study of 34 patients (64 eyes) was conducted. The patients were divided into three groups, patients received intravitreal IVB (IVB group), patients received combined IVB and laser treatment (IVB+Laser group), or patients received lens-sparing vitrectomy (IVB+LSV group). Cycloplegic refraction and axial length (AXL) were evaluated at 2 years old.ResultsThe prevalences of myopia and high myopia were 47.5 and 10.0% in the IVB group, respectively, which were lower than those in the IVB+Laser (82.4 and 29.4%) and IVB+LSV (all 100%) groups (P=0.001 and P<0.001). The prevalences of emmetropia in the IVB group, IVB+Laser group, and IVB+LSV group were 50, 5.9, and 0% (P=0.001). The AXL were similar among all groups. Conclusions At the 2-year follow-up, severe ROP patients treated with IVB alone were more likely to remain emmetropic and had lower prevalences of myopia and high myopia. The development of high myopia in severe ROP patients could not be explained by AXL changes but may be associated with abnormalities in the anterior segment.

Original languageEnglish
Pages (from-to)1080-1087
Number of pages8
JournalEye (Basingstoke)
Volume28
Issue number9
DOIs
StatePublished - 11 09 2014
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2014 Macmillan Publishers Limited All rights reserved.

Fingerprint

Dive into the research topics of 'Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes'. Together they form a unique fingerprint.

Cite this